- Time:
Special Guests:
- Cigall Kadoch, PhD – Associate Professor of Pediatrics, Harvard Medical School, Founder, Foghorn Therapeutics
- Tobiloba Oni, PhD – Whitehead Fellow, Whitehead Institute
Despite a budget of more than $6 billion allocated to the National Cancer Institute and a highly publicized cancer moonshot, the development of new cancer treatments remains a daunting challenge. Some of the promising new frontiers in cancer drug development focus on areas such as immune modulation, epigenetics, and even harnessing the microbiome. The promise of the next big treatment breakthrough lies just around the corner.
In the September edition of GEN Live, we’re joined by leaders in the field to discuss where cancer research is now, the challenges it faces as it moves forward, and to preview the innovative new ways that cancer is being targeted to develop future therapies.
Co-hosts:
Webinar produced with support from:
Powerful biology accelerating the future of medicine
Associate Professor of Pediatrics,
Harvard Medical School
Founder, Foghorn Therapeutics
Whitehead Fellow
Whitehead Institute
